Skip to main content

Angiogenesis-related Growth Factors in Brain Tumors

  • Chapter
Angiogenesis in Brain Tumors

Part of the book series: Cancer Treatment and Research ((CTAR,volume 117))

Abstract

Numerous growth factors have been implicated in glioma angiogenesis. This chapter focuses on the role of scatter factor/hepatocyte growth factor, fibroblast growth factor, platelet-derived growth factor and transforming growth factor P. We review the expression pattern of these factors in gliomas, their functional contribution to tumor angiogenesis — also in relation to vascular endothelial growth factor, and the effects resulting from their inhibition or overexpression in gliomas in vivo.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Abounader R, Lal B, Luddy C, Koe G, Davidson B, Rosen EM, Laterra J: In vivo targeting of SF/HGF and c-met expression via UI snRNA/ribozymes inhibits glioma growth and angiogenesis and promotes apoptosis. FASEB J 2002, 16:108–10.

    PubMed  CAS  Google Scholar 

  2. Abounader R, Ranganathan S, Lal B, Fielding K, Book A, Dietz H, Burger P, Laterra J: Reversion of human glioblastoma malignancy by UI small nuclear RNA/ribozyme targeting of scatter factor/hepatocyte growth factor and c-met expression. J Natl Cancer Inst 1999, 91:1548–56.

    Article  PubMed  CAS  Google Scholar 

  3. Armelin HA: Pituitary extracts and steroid hormones in the control of 3T3 cell growth. Proc Natl Acad Sci U S A 1973, 70:2702–6.

    Article  PubMed  CAS  Google Scholar 

  4. Ashley DM, Kong FM, Bigner DD, Hale LP: Endogenous expression of transforming growth factor betal inhibits growth and tumorigenicity and enhances Fas-mediated apoptosis in a murine high-grade glioma model. Cancer Res 1998, 58:302–9.

    PubMed  CAS  Google Scholar 

  5. Auguste P, Gursel DB, Lemiere S, Reimers D, Cuevas P, Carceller F, Di Santo JP, Bikfalvi A: Inhibition of fibroblast growth factor/fibroblast growth factor receptor activity in glioma cells impedes tumor growth by both angiogenesis-dependent and - independent mechanisms. Cancer Res 2001, 61:1717–26.

    PubMed  CAS  Google Scholar 

  6. Basilico C, Moscatelli D: The FGF family of growth factors and oncogenes. Adv Cancer Res 1992, 59:115–65.

    Article  PubMed  CAS  Google Scholar 

  7. Battegay EJ, Rupp J, Iruela-Arispe L, Sage EH, Pech M: PDGF-BB modulates endothelial proliferation and angiogenesis in vitro via PDGF beta-receptors. J Cell Biol 1994, 125:917–28.

    Article  PubMed  CAS  Google Scholar 

  8. Bello L, Lucini V, Carrabba G, Giussani C, Machluf M, Pluderi M, Nikas D, Zhang J, Tomei G, Villani RM, Carroll RS, Bikfalvi A, Black PM: Simultaneous inhibition of glioma angiogenesis, cell proliferation, and invasion by a naturally occurring fragment of human metalloproteinase-2. Cancer Res 2001, 61:8730–6.

    PubMed  CAS  Google Scholar 

  9. Betsholtz C, Karlsson L, Lindahl P: Developmental roles of platelet-derived growth factors. Bioessays 2001, 23:494–507.

    Article  PubMed  CAS  Google Scholar 

  10. Bikfalvi A, Klein S, Pintucci G, Rifkin DB: Biological roles of fibroblast growth factor-2. Endocr Rev 1997, 18:26–45.

    Article  PubMed  CAS  Google Scholar 

  11. Bladt F, Riethmacher D, Isenmann S, Aguzzi A, Birchmeier C: Essential role for the c-met receptor in the migration of myogenic precursor cells into the limb bud. Nature 1995, 376:768–71.

    Article  PubMed  CAS  Google Scholar 

  12. Blaskovich MA, Lin Q, Delarue FL, Sun J, Park HS, Coppola D, Hamilton AD, Sebti SM: Design of GFB-111, a platelet-derived growth factor binding molecule with antiangiogenic and anticancer activity against human tumors in mice. Nat Biotechnol 2000, 18:1065–70.

    Article  PubMed  CAS  Google Scholar 

  13. Book AA, Ranganathan S, Abounader R, Rosen E, Laterra J: Scatter factor/hepatocyte growth factor gene transfer increases rat blood-glioma barrier permeability. Brain Res 1999, 833:173–80.

    Article  PubMed  CAS  Google Scholar 

  14. Brem S, Tsanaclis AM, Gately S, Gross JL, Herblin WF: Immunolocalization of basic fibroblast growth factor to the microvasculature of human brain tumors. Cancer 1992, 70:2673–80.

    Article  PubMed  CAS  Google Scholar 

  15. Bussolino F, Di Renzo MF, Ziche M, Bocchietto E, Olivero M, Naldini L, Gaudino G, Tamagnone L, Coffer A, Comoglio PM: Hepatocyte growth factor is a potent angiogenic factor which stimulates endothelial cell motility and growth. J Cell Biol 1992, 119:629–41.

    Article  PubMed  CAS  Google Scholar 

  16. Cooper CS, Park M, Blair DG, Tainsky MA, Huebner K, Croce CM, Vande Woude GF: Molecular cloning of a new transforming gene from a chemically transformed human cell line. Nature 1984, 311:29–33.

    Article  PubMed  CAS  Google Scholar 

  17. Dickson MC, Martin JS, Cousins FM, Kulkarni AB, Karlsson S, Akhurst RJ: Defective haematopoiesis and vasculogenesis in transforming growth factor-beta 1 knock out mice. Development 1995, 121:1845–54.

    PubMed  CAS  Google Scholar 

  18. Fajardo LF, Prionas SD, Kwan HH, Kowalski J, Allison AC: Transforming growth factor betal induces angiogenesis in vivo with a threshold pattern. Lab Invest 1996, 74:600–8.

    PubMed  CAS  Google Scholar 

  19. Fakhrai H, Dorigo O, Shawler DL, Lin H, Mercola D, Black KL, Royston I, Sobol RE: Eradication of established intracranial rat gliomas by transforming growth factor beta antisense gene therapy. Proc Natl Acad Sci U S A 1996, 93:2909–14.

    Article  PubMed  CAS  Google Scholar 

  20. Fernandez B, Buehler A, Wolfram S, Kostin S, Espanion G, Franz WM, Niemann H, Doevendans PA, Schaper W, Zimmermann R: Transgenic myocardial overexpression of fibroblast growth factor-1 increases coronary artery density and branching. Circ Res 2000, 87:207–13.

    Article  PubMed  CAS  Google Scholar 

  21. Folkman J, Klagsbrun M: Angiogenic factors. Science 1987, 235:442–7.

    Article  PubMed  CAS  Google Scholar 

  22. Fulgham DL, Widhalm SR, Martin S, Coffin JD: FGF-2 dependent angiogenesis is a latent phenotype in basic fibroblast growth factor transgenic mice. Endothelium 1999, 6:185–95.

    Article  PubMed  CAS  Google Scholar 

  23. Gospodarowicz D, Ferrara N, Schweigerer L, Neufeld G: Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 1987, 8:95–114.

    Article  PubMed  CAS  Google Scholar 

  24. Gospodarowicz D, Jones KL, Sato G: Purification of a growth factor for ovarian cells from bovine pituitary glands. Proc Natl Acad Sci U S A 1974, 71:2295–9.

    Article  PubMed  CAS  Google Scholar 

  25. Grant DS, Kleinman HK, Goldberg ID, Bhargava MM, Nickoloff BJ, Kinsella JL, Polverini P, Rosen EM: Scatter factor induces blood vessel formation in vivo. Proc Natl Acad Sci USA 1993, 90:1937–41.

    Article  PubMed  CAS  Google Scholar 

  26. Gross JL, Herblin WF, Dusak BA, Czerniak P, Diamond MD, Sun T, Eidsvoog K, Dexter DL, Yayon A: Effects of modulation of basic fibroblast growth factor on tumor growth in vivo. J Natl Cancer Inst 1993, 85:121–31.

    Article  PubMed  Google Scholar 

  27. Guha A, Dashner K, Black PM, Wagner JA, Stiles CD: Expression of PDGF and PDGF receptors in human astrocytoma operation specimens supports the existence of an autocrine loop. Int J Cancer 1995, 60:168–73.

    Article  PubMed  CAS  Google Scholar 

  28. Hamel W, Westphal M: Growth factors in gliomas revisited. Acta Neurochir (Wien) 2000, 142:113–37; discussion 113–37

    Article  Google Scholar 

  29. Heldin CH, Eriksson U, Ostman A: New members of the platelet-derived growth factor family of mitogens. Arch Biochem Biophys 2002, 398:284–90.

    Article  PubMed  CAS  Google Scholar 

  30. Heldin CH, Westermark B: Mechanism of action and in vivo role of platelet-derived growth factor. Physiol Rev 1999, 79:1283–316.

    PubMed  CAS  Google Scholar 

  31. Hermanson M, Funa K, Hartman M, Claesson-Welsh L, Heldin CH, Westermark B, Nister M: Platelet-derived growth factor and its receptors in human glioma tissue: expression of messenger RNA and protein suggests the presence of autocrine and paracrine loops. Cancer Res 1992, 52:3213–9.

    PubMed  CAS  Google Scholar 

  32. Hermansson M, Nister M, Betsholtz C, Heldin CH, Westermark B, Funa K: Endothelial cell hyperplasia in human glioblastoma: coexpression of mRNA for platelet-derived growth factor (PDGF) B chain and PDGF receptor suggests autocrine growth stimulation. Proc Natl Acad Sci U S A 1988, 85:7748–52.

    Article  PubMed  CAS  Google Scholar 

  33. Horiguchi N, Takayama H, Toyoda M, Otsuka T, Fukusato T, Merlino G, Takagi H, Mori M: Hepatocyte growth factor promotes hepatocarcinogenesis through c-Met autocrine activation and enhanced angiogenesis in transgenic mice treated with diethylnitrosamine. Oncogene 2002, 21:1791–9.

    Article  PubMed  CAS  Google Scholar 

  34. Horst HA, Scheithauer BW, Kelly PJ, Kovach JS: Distribution of transforming growth factor-beta 1 in human astrocytomas. Hum Pathol 1992, 23:1284–8.

    Article  PubMed  CAS  Google Scholar 

  35. Ignotz RA, Endo T, Massague J: Regulation of fibronectin and type I collagen mRNA levels by transforming growth factor-beta. J Biol Chem 1987, 262:6443–6.

    PubMed  CAS  Google Scholar 

  36. Kalkanis SN, Carroll RS, Zhang J, Zamani AA, Black PM: Correlation of vascular endothelial growth factor messenger RNA expression with peritumoral vasogenic cerebral edema in meningiomas. J Neurosurg 1996, 85:1095–101.

    Article  PubMed  CAS  Google Scholar 

  37. Kavanaugh WM, Harsh GR 4th, Starksen NF, Rocco CM, Williams LT: Transcriptional regulation of the A and B chain genes of platelet-derived growth factor in microvascular endothelial cells. J Biol Chem 1988, 263:8470–2.

    PubMed  CAS  Google Scholar 

  38. Khachigian LM, Field SL, Crouch R, Chesterman CN: Platelet-derived growth factor A-chain synthetic peptide inhibits human glioma xenograft proliferation in nude mice. Anticancer Res 1995, 15:337–41.

    PubMed  CAS  Google Scholar 

  39. Kilic T, Alberta JA, Zdunek PR, Acar M, Iannarelli P, O’Reilly T, Buchdunger E, Black PM, Stiles CD: Intracranial inhibition of platelet-derived growth factor-mediated glioblastoma cell growth by an orally active kinase inhibitor of the 2phenylaminopyrimidine class. Cancer Res 2000, 60:5143–50.

    PubMed  CAS  Google Scholar 

  40. Koochekpour S, Jeffers M, Rulong S, Taylor G, Klineberg E, Hudson EA, Resau JH, Vande Woude GF: Met and hepatocyte growth factor/scatter factor expression in human gliomas. Cancer Res 1997, 57:5391–8.

    PubMed  CAS  Google Scholar 

  41. Koochekpour S, Merzak A, Pilkington GJ: Vascular endothelial growth factor production is stimulated by gangliosides and TGF-beta isoforms in human glioma cells in vitro. Cancer Lett 1996, 102:209–15.

    Article  PubMed  CAS  Google Scholar 

  42. Kunkel P, Muller S, Schirmacher P, Stavrou D, Fillbrandt R, Westphal M, Lamszus K: Expression and localization of scatter factor/hepatocyte growth factor in human astrocytomas. Neuro-oncol 2001a, 3:82–8.

    CAS  Google Scholar 

  43. Kunkel P, Ulbricht U, Bohlen P, Brockmann MA, Fillbrandt R, Stavrou D, Westphal M, Lamszus K: Inhibition of glioma angiogenesis and growth in vivo by systemic treatment with a monoclonal antibody against vascular endothelial growth factor receptor-2. Cancer Res 2001b, 61:6624–8.

    CAS  Google Scholar 

  44. Lamszus K, Laterra J, Westphal M, Rosen EM: Scatter factor/hepatocyte growth factor (SF/HGF) content and function in human gliomas. Int J Dev Neurosci 1999a, 17:51730.

    Article  Google Scholar 

  45. Lamszus K, Lengler U, Schmidt NO, Stavrou D, Ergun S, Westphal M: Vascular endothelial growth factor, hepatocyte growth factor/scatter factor, basic fibroblast growth factor, and placenta growth factor in human meningiomas and their relation to angiogenesis and malignancy. Neurosurgery 2000, 46:938–47.

    PubMed  CAS  Google Scholar 

  46. Lamszus K, Schmidt NO, Ergun S, Westphal M: Isolation and culture of human neuromicrovascular endothelial cells for the study of angiogenesis in vitro. J Neurosci Res 1999b, 55:370–81.

    Article  CAS  Google Scholar 

  47. Lamszus K, Schmidt NO, Jin L, Laterra J, Zagzag D, Way D, Witte M, Weinand M, Goldberg ID, Westphal M, Rosen EM: Scatter factor promotes motility of human glioma and neuromicrovascular endothelial cells. Int J Cancer 1998, 75:19–28.

    Article  PubMed  CAS  Google Scholar 

  48. Larsson J, Goumans MJ, Sjostrand U, van Rooijen MA, Ward D, Leveen P, Xu X, ten Dijke P, Mummery CL, Karlsson S: Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice. EMBO J 2001, 20:1663–73.

    Article  PubMed  CAS  Google Scholar 

  49. Laterra J, Nam M, Rosen E, Rao JS, Lamszus K, Goldberg ID, Johnston P: Scatter factor/hepatocyte growth factor gene transfer enhances glioma growth and angiogenesis in vivo. Lab Invest 1997, 76:565–77.

    PubMed  CAS  Google Scholar 

  50. Lee SH, Schloss DJ, Swain JL: Maintenance of vascular integrity in the embryo requires signaling through the fibroblast growth factor receptor. J Biol Chem 2000, 275:33679–87.

    Article  PubMed  CAS  Google Scholar 

  51. Liau LM, Fakhrai H, Black KL: Prolonged survival of rats with intracranial C6 gliomas by treatment with TGF-beta antisense gene. Neurol Res 1998, 20:742–7.

    PubMed  CAS  Google Scholar 

  52. Marx M, Perlmutter RA, Madri JA: Modulation of platelet-derived growth factor receptor expression in microvascular endothelial cells during in vitro angiogenesis. J Clin Invest 1994, 93:131–9.

    Article  PubMed  CAS  Google Scholar 

  53. Massague J: The transforming growth factor-beta family. Annu Rev Cell Biol 1990, 6:597–641.

    Article  PubMed  CAS  Google Scholar 

  54. Massague J: TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753–91.

    Article  PubMed  CAS  Google Scholar 

  55. Maxwell M, Naber SP, Wolfe HJ, Galanopoulos T, Hedley-Whyte ET, Black PM, Antoniades HN: Coexpression of platelet-derived growth factor (PDGF) and PDGFreceptor genes by primary human astrocytomas may contribute to their development and maintenance. J Clin Invest 1990, 86:131–40.

    Article  PubMed  CAS  Google Scholar 

  56. Merwin JR, Newman W, Beall LD, Tucker A, Madri J: Vascular cells respond differentially to transforming growth factors beta 1 and beta 2 in vitro. Am J Pathol 1991, 138:37–51.

    PubMed  CAS  Google Scholar 

  57. Mignatti P, Morimoto T, Rifkin DB: Basic fibroblast growth factor, a protein devoid of secretory signal sequence, is released by cells via a pathway independent of the endoplasmic reticulum-Golgi complex. J Cell Physiol 1992, 151:81–93.

    Article  PubMed  CAS  Google Scholar 

  58. Miller DL, Ortega S, Bashayan O, Basch R, Basilico C: Compensation by fibroblast growth factor 1 (FGF1) does not account for the mild phenotypic defects observed in FGF2 null mice. Mol Cell Biol 2000, 20:2260–8.

    Article  PubMed  CAS  Google Scholar 

  59. Moriyama T, Kataoka H, Hamasuna R, Yokogami K, Uehara H, Kawano H, Goya T, Tsubouchi H, Koono M, Wakisaka S: Up-regulation of vascular endothelial growth factor induced by hepatocyte growth factor/scatter factor stimulation in human glioma cells. Biochem Biophys Res Commun 1998, 249:73–7.

    Article  PubMed  CAS  Google Scholar 

  60. Morrison RS, Yamaguchi F, Bruner JM, Tang M, McKeehan W, Berger MS: Fibroblast growth factor receptor gene expression and immunoreactivity are elevated in human glioblastoma multiforme. Cancer Res 1994, 54:2794–9.

    PubMed  CAS  Google Scholar 

  61. Moses HL, Branum EL, Proper JA, Robinson RA: Transforming growth factor production by chemically transformed cells. Cancer Res 1981, 41:2842–8.

    PubMed  CAS  Google Scholar 

  62. Muller G, Behrens J, Nussbaumer U, Bohlen P, Birchmeier W: Inhibitory action of transforming growth factor beta on endothelial cells. Proc Natl Acad Sci U S A 1987, 84:5600–4.

    Article  PubMed  CAS  Google Scholar 

  63. Nabeshima K, Shimao Y, Sato S, Kataoka H, Moriyama T, Kawano H, Wakisaka S, Koono M: Expression of c-Met correlates with grade of malignancy in human astrocytic tumours: an immunohistochemical study. Histopathology 1997, 31:436–43.

    Article  PubMed  CAS  Google Scholar 

  64. Nakamura T, Teramoto H, Ichihara A: Purification and characterization of a growth factor from rat platelets for mature parenchymal hepatocytes in primary cultures. Proc Natl Acad Sci U S A 1986, 83:6489–93.

    Article  PubMed  CAS  Google Scholar 

  65. Nicosia RF, Nicosia SV, Smith M: Vascular endothelial growth factor, platelet-derived growth factor, and insulin-like growth factor-1 promote rat aortic angiogenesis in vitro. Am J Pathol 1994, 145:1023–9.

    PubMed  CAS  Google Scholar 

  66. Ortega S, Ittmann M, Tsang SH, Ehrlich M, Basilico C: Neuronal defects and delayed wound healing in mice lacking fibroblast growth factor 2. Proc Natl Acad Sci U S A 1998, 95:5672–7.

    Article  PubMed  CAS  Google Scholar 

  67. Oshima M, Oshima H, Taketo MM: TGF-beta receptor type II deficiency results in defects of yolk sac hematopoiesis and vasculogenesis. Dev Biol 1996, 179:297–302.

    Article  PubMed  CAS  Google Scholar 

  68. Pepper MS, Ferrara N, Orci L, Montesano R: Potent synergism between vascular endothelial growth factor and basic fibroblast growth factor in the induction of angiogenesis in vitro. Biochem Biophys Res Commun 1992, 189:824–31.

    Article  PubMed  CAS  Google Scholar 

  69. Plate KH: Mechanisms of angiogenesis in the brain. J Neuropathol Exp Neural 1999, 58:313–20.

    Article  CAS  Google Scholar 

  70. Plate KH, Breier G, Farrell CL, Risau W: Platelet-derived growth factor receptor-beta is induced during tumor development and upregulated during tumor progression in endothelial cells in human gliomas. Lab Invest 1992, 67:529–34.

    PubMed  CAS  Google Scholar 

  71. Plate KH, Breier G, Risau W: Molecular mechanisms of developmental and tumor angiogenesis. Brain Pathol 1994, 4:207–18.

    Article  PubMed  CAS  Google Scholar 

  72. Powers CJ, McLeskey SW, Wellstein A: Fibroblast growth factors, their receptors and signaling. Endocr Relat Cancer 2000, 7:165–97.

    Article  PubMed  CAS  Google Scholar 

  73. Risau W: What, if anything, is an angiogenic factor? Cancer Metastasis Rev 1996, 15:149–51.

    Article  PubMed  CAS  Google Scholar 

  74. Risau W, Drexler H, Mironov V, Smits A, Siegbahn A, Funa K, Heldin CH: Platelet-derived growth factor is angiogenic in vivo. Growth Factors 1992, 7:261–6.

    Article  PubMed  CAS  Google Scholar 

  75. Rosen EM, Grant D, Kleinman H, Jaken S, Donovan MA, Setter E, Luckett PM, Carley W: Scatter factor stimulates migration of vascular endothelium and capillary-like tube formation. In: Cell motility factors, Goldberg ID, Rosen EM (eds), Basel, BirkhäuserVerlag, 1991, pp. 76–88.

    Google Scholar 

  76. Rosen EM, Lamszus K, Fan S, Goldberg ID, Laterra J, Polverini PJ: Scatter factor as a tumor angiogenesis factor. In: Angiogenesis in health and disease: basic mechanisms and clinical applications, Rubanyi GM (ed), Basel, Marcel Dekker, Inc., 2000, pp. 145156.

    Google Scholar 

  77. Rosen EM, Laterra J, Joseph A, Jin L, Fuchs A, Way D, Witte M, Weinand M, Goldberg ID: Scatter factor expression and regulation in human glial tumors. Int J Cancer 1996, 67:248–55.

    Article  PubMed  CAS  Google Scholar 

  78. Rousseau B, Dubayle D, Sennlaub F, Jeanny JC, Costet P, Bikfalvi A, Javerzat S: Neural and angiogenic defects in eyes of transgenic mice expressing a dominant-negative FGF receptor in the pigmented cells. Exp Eye Res 2000, 71:395–404.

    Article  PubMed  CAS  Google Scholar 

  79. Rubenstein JL, Kim J, Ozawa T, Zhang M, Westphal M, Deen DF, Shuman MA: AntiVEGF antibody treatment of glioblastoma prolongs survival but results in increased vascular cooption. Neoplasia 2000, 2:306–14.

    Article  PubMed  CAS  Google Scholar 

  80. Samoto K, Ikezaki K, Ono M, Shono T, Kohno K, Kuwano M, Fukui M: Expression of vascular endothelial growth factor and its possible relation with neovascularization in human brain tumors. Cancer Res 1995, 55:1189–93.

    PubMed  CAS  Google Scholar 

  81. Sato N, Beitz JG, Kato J, Yamamoto M, Clark JW, Calabresi P, Raymond A, Frackelton AR Jr: Platelet-derived growth factor indirectly stimulates angiogenesis in vitro. Am J Pathol 1993, 142:1119–30.

    PubMed  CAS  Google Scholar 

  82. Schmidt C, Bladt F, Goedecke S, Brinkmann V, Zschiesche W, Sharpe M, Gherardi E, Birchmeier C: Scatter factor/hepatocyte growth factor is essential for liver development. Nature 1995, 373:699–702.

    Article  PubMed  CAS  Google Scholar 

  83. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G, Choyke P, Scherer SW, Zhuang Z, Lubensky I, Dean M, Allikmets R, Chidambaram A, Bergerheim UR, Feltis JT, Casadevall C, Zamarron A, Bernues M, Richard S, Lips CJ, Walther MM, Tsui LC, Geil L, Orcutt ML, Stackhouse T, Zbar B, et al: Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat Genet 1997, 16:68–73.

    Article  PubMed  CAS  Google Scholar 

  84. Schmidt NO, Westphal M, Hagel C, Ergun S, Stavrou D, Rosen EM, Lamszus K: Levels of vascular endothelial growth factor, hepatocyte growth factor/scatter factor and basic fibroblast growth factor in human gliomas and their relation to angiogenesis. Int J Cancer 1999, 84:10–8.

    Article  PubMed  CAS  Google Scholar 

  85. Schwartz SM, Liaw L: Growth control and morphogenesis in the development and pathology of arteries. J Cardiovasc Pharmacol 1993, 21 Suppl 1:S31–49.

    PubMed  Google Scholar 

  86. Shing Y, Folkman J, Sullivan R, Butterfield C, Murray J, Klagsbrun M: Heparin affinity: purification of a tumor-derived capillary endothelial cell growth factor. Science 1984, 223:1296–9.

    Article  PubMed  CAS  Google Scholar 

  87. Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D, et al: Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 1992, 359:693–9.

    Article  PubMed  CAS  Google Scholar 

  88. Stan AC, Nemati MN, Pietsch T, Walter GF, Dietz H: In vivo inhibition of angiogenesis and growth of the human U-87 malignant glial tumor by treatment with an antibody against basic fibroblast growth factor. J Neurosurg 1995, 82:1044–52.

    Article  PubMed  CAS  Google Scholar 

  89. Stefanik DF, Rizkalla LR, Soi A, Goldblatt SA, Rizkalla WM: Acidic and basic fibroblast growth factors are present in glioblastoma multiforme. Cancer Res 1991, 51:5760–5.

    PubMed  CAS  Google Scholar 

  90. Stiles JD, Ostrow PT, Balos LL, Greenberg SJ, Plunkett R, Grand W, Heffner RR Jr: Correlation of endothelin-1 and transforming growth factor beta 1 with malignancy and vascularity in human gliomas. J Neuropathol Exp Neurol 1997, 56:435–9.

    Article  PubMed  CAS  Google Scholar 

  91. Stoker M, Gherardi E, Perryman M, Gray J: Scatter factor is a fibroblast-derived modulator of epithelial cell mobility. Nature 1987, 327:239–42.

    Article  PubMed  CAS  Google Scholar 

  92. Strawn LM, Mann E, Elliger SS, Chu LM, Germain LL, Niederfellner G, Ullrich A, Shawver LK: Inhibition of glioma cell growth by a truncated platelet-derived growth factor-beta receptor. J Biol Chem 1994, 269:21215–22.

    PubMed  CAS  Google Scholar 

  93. Takahashi JA, Fukumoto M, Igarashi K, Oda Y, Kikuchi H, Hatanaka M: Correlation of basic fibroblast growth factor expression levels with the degree of malignancy and vascularity in human gliomas. J Neurosurg 1992, 76:792–8.

    Article  PubMed  CAS  Google Scholar 

  94. Takahashi JA, Fukumoto M, Kozai Y, Ito N, Oda Y, Kikuchi H, Hatanaka M: Inhibition of cell growth and tumorigenesis of human glioblastoma cells by a neutralizing antibody against human basic fibroblast growth factor. FEBS Lett 1991, 288:65–71.

    Article  PubMed  CAS  Google Scholar 

  95. Takahashi JA, Mori H, Fukumoto M, Igarashi K, Jaye M, Oda Y, Kikuchi H, Hatanaka M: Gene expression of fibroblast growth factors in human gliomas and meningiomas: demonstration of cellular source of basic fibroblast growth factor mRNA and peptide in tumor tissues. Proc Natl Acad Sci U S A 1990, 87:5710–4.

    Article  PubMed  CAS  Google Scholar 

  96. Takayama H, La Rochelle WJ, Anver M, Bockman DE, Merlino G: Scatter factor/hepatocyte growth factor as a regulator of skeletal muscle and neural crest development. Proc Natl Acad Sci U S A 1996, 93:5866–71.

    Article  PubMed  CAS  Google Scholar 

  97. Takayama H, LaRochelle WJ, Sharp R, Otsuka T, Kriebel P, Anver M, Aaronson SA, Merlino G: Diverse tumorigenesis associated with aberrant development in mice overexpressing hepatocyte growth factor/scatter factor. Proc Natl Acad Sci U S A 1997, 94:701–6.

    Article  PubMed  CAS  Google Scholar 

  98. Thommen R, Humar R, Misevic G, Pepper MS, Hahn AW, John M, Battegay EJ: PDGF-BB increases endothelial migration on cord movements during angiogenesis in vitro. J Cell Biochem 1997, 64:403–13.

    Article  PubMed  CAS  Google Scholar 

  99. Toyoda M, Takayama H, Horiguchi N, Otsuka T, Fukusato T, Merlin G, Takagi H, Mori M: Overexpression of hepatocyte growth factor/scatter factor promotes vascularization and granulation tissue formation in vivo. FEBS Lett 2001, 509:95–100.

    Article  PubMed  CAS  Google Scholar 

  100. Tsai JC, Goldman CK, Gillespie GY: Vascular endothelial growth factor in human glioma cell lines: induced secretion by EGF, PDGF-BB, and bFGF. J Neurosurg 1995, 82:864–73.

    Article  PubMed  CAS  Google Scholar 

  101. Ueba T, Takahashi JA, Fukumoto M, Ohta M, Ito N, Oda Y, Kikuchi H, Hatanaka M: Expression of fibroblast growth factor receptor-1 in human glioma and meningioma tissues. Neurosurgery 1994, 34:221–5.

    Article  PubMed  CAS  Google Scholar 

  102. Uehara Y, Minowa O, Mori C, Shiota K, Kuno J, Noda T, Kitamura N: Placental defect and embryonic lethality in mice lacking hepatocyte growth factor/scatter factor. Nature 1995, 373:702–5.

    Article  PubMed  CAS  Google Scholar 

  103. Van Belle E, Witzenbichler B, Chen D, Silver M, Chang L, Schwall R, Isner JM: Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: the case for paracrine amplification of angiogenesis. Circulation 1998, 97:381–90.

    Article  PubMed  Google Scholar 

  104. Verbeek MM, Otte-Holler I, Wesseling P, Ruiter DJ, de Waal RM: Induction of alpha-smooth muscle actin expression in cultured human brain pericytes by transforming growth factor-beta 1. Am J Pathol 1994, 144:372–82.

    PubMed  CAS  Google Scholar 

  105. Vinals F, Pouyssegur J: Transforming growth factor betal (TGF-betal) promotes endothelial cell survival during in vitro angiogenesis via an autocrine mechanism implicating TGF-alpha signaling. Mol Cell Biol 2001, 21:7218–30.

    Article  PubMed  CAS  Google Scholar 

  106. Westphal M, Brunken M, Rohde E, Herrmann HD: Growth factors in cultured human glioma cells: differential effects of FGF, EGF and PDGF. Cancer Lett 1988, 38:283–96.

    Article  PubMed  CAS  Google Scholar 

  107. Yamada N, Kato M, Yamashita H, Nister M, Miyazono K, Heldin CH, Funa K: Enhanced expression of transforming growth factor-beta and its type-I and type-II receptors in human glioblastoma. Int J Cancer 1995, 62:386–92.

    Article  PubMed  CAS  Google Scholar 

  108. Yamaguchi F, Saya H, Bruner.TM, Morrison RS: Differential expression of two fibroblast growth factor-receptor genes is associated with malignant progression in human astrocytomas. Proc Natl Acad Sci USA 1994, 91:484–8.

    Article  PubMed  CAS  Google Scholar 

  109. Yang EY, Moses HL: Transforming growth factor beta 1-induced changes in cell migration, proliferation, and angiogenesis in the chicken chorioallantoic membrane. J Cell Biol 1990, 111:731–41.

    Article  PubMed  CAS  Google Scholar 

  110. Zagzag D, Miller DC, Sato Y, Rifkin DB, Burstein DE: Immunohistochemical localization of basic fibroblast growth factor in astrocytomas. Cancer Res 1990, 50:7393–8.

    PubMed  CAS  Google Scholar 

  111. Zhou M, Sutliff RL, Paul RJ, Lorenz JN, Hoying JB, Haudenschild CC, Yin M, Coffin JD, Kong L, Kranias EG, Luo W, Boivin GP, Duffy JJ, Pawlowski SA, Doetschman T: Fibroblast growth factor 2 control of vascular tone. Nat Med 1998, 4:201–7.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2004 Springer Science+Business Media New York

About this chapter

Cite this chapter

Lamszus, K., Heese, O., Westphal, M. (2004). Angiogenesis-related Growth Factors in Brain Tumors. In: Kirsch, M., Black, P.M. (eds) Angiogenesis in Brain Tumors. Cancer Treatment and Research, vol 117. Springer, Boston, MA. https://doi.org/10.1007/978-1-4419-8871-3_12

Download citation

  • DOI: https://doi.org/10.1007/978-1-4419-8871-3_12

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4613-4699-9

  • Online ISBN: 978-1-4419-8871-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics